The federal contract IDV award is to Golden State Medical Supply, Inc. (a for-profit manufacturer and distributor of pharmaceutical products) to provide Buspirone HCL tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a ceiling value of $16,423,902.10 and a period of performance from August 7, 2020 to August 6, 2025, with a base year and four one-year option periods.
The contract was awarded by the VA National Acquisition Center through a pre-solicitation (Solicitation #36E79720R0026) posted on March 13, 2020, which sought an unrestricted procurement for Buspirone tablets. The estimated annual requirements include various package sizes and strengths of the Buspirone HCL tablets, totaling over 500,000 bottles per year. The contract enables the VA, DoD, BOP, and IHS to place delivery orders against the established price schedules or issue task orders for the standard pharmaceutical products. This contract supports the agencies' needs for critical medications used to treat conditions such as anxiety, epilepsy, high cholesterol, and hypertension.
Generated 7/25/24, 9:11 AM